Gender-affirming hormone therapy in transgender women and risk of prostate cancer: pathophysiological mechanisms and clinical implications.

Prostate cancer and prostatic diseases. 2024 Jan 31 [Epub ahead of print]

Eugenio Bologna, Leslie Claire Licari, Antonio Franco, Francesco Ditonno, Costantino Leonardo, Cosimo De Nunzio, Riccardo Autorino, Celeste Manfredi

Department of Urology, Rush University, Chicago, IL, USA. , Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy., Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy., Department of Urology, Rush University, Chicago, IL, USA. .

PubMed http://www.ncbi.nlm.nih.gov/pubmed/38297151